Queen Square Centre for Neuromuscular Diseases

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Myasthenia gravis1 trial

Phase

• Phase 31 trial

Status

• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 trial
• University College London Hospitals1 trial

Running trials

• Recruiting

  Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  NCT06463587· Phase 3· Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany· Source

  Contact: Jennifer Spillane (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Myasthenia gravis1 recruiting

Closed trials

• Completed

  Muscle Structure, Function and Gait in dHMN

  NCT04193228· University College London Hospitals· Source